Microtubule-destabilizing protein stathmin-2 (STMN2), whose levels are decreased in the majority of ALS cases (Klim et al, 2019; Prudencio et al, 2020), was also implicated in the maintenance of Golgi structure (Strey et al, 2004; Bellouze et al, 2016). Here, STMN2 is linked to amyotrophic lateral sclerosis.